Striatal Proteomic Analysis Suggests that First L-Dopa Dose Equates to Chronic Exposure
Birger Scholz(Uppsala University), Per E. Andrén(Uppsala University), Évelyne Doudnikoff(Victor (Japan)), Alan R. Crossman(Motac Neuroscience (United Kingdom)), Kim Kultima(Uppsala University), Maria Fälth(Uppsala University), Qin Li(Yangtze University), Céline Guigoni(Institut Interdisciplinaire de Neuroscience), Karl Sköld(Uppsala University), Erwan Bézard(Centre National de la Recherche Scientifique), Marcus Svensson(Karolinska University Hospital), Henrik Alm(Uppsala University)
Cited by 46
Related Papers
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy
|Movement Disorders|2017|846
Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations
|The Lancet Neurology|2015|508
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease
|Progress in Neurobiology|2015|472
Priorities in Parkinson's disease research
|Nature Reviews Drug Discovery|2011|430
Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function
|Nature Medicine|2003|381